Evidence map›Paper›PMID 25872027›Full record

Trial reportTrials2015

Open versus laparoscopic liver resection for colorectal liver metastases (the Oslo-CoMet Study): study protocol for a randomized controlled trial.

Åsmund Avdem Fretland, Airazat M Kazaryan, Bjørn Atle Bjørnbeth, Kjersti Flatmark, Marit Helen Andersen, Tor Inge Tønnessen, Gudrun Maria Waaler Bjørnelv, Morten Wang Fagerland, Ronny Kristiansen, Karl Øyri and 1 more

Registry-linked trialAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01516710 (Prospective Randomized Study of Laparoscopic Versus Open Liver Resection for Colorectal Metastases), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01516710 naunknown statusnot on this map

Prospective Randomized Study of Laparoscopic Versus Open Liver Resection for Colorectal Metastases

TypeinterventionalSponsorOslo University HospitalRan2012 to 2025Enrolled280ConditionsSecondary Malignant Neoplasm of Liver, Colorectal NeoplasmsArmsOpen liver resection, Laparoscopic liver resection
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Is operation time over the benchmark value a risk factor for worse short-term outcomes after laparoscopic liver resection?Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2024
    Article
  10. Article
  11. ACancer research communications · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Laparoscopic Liver Resection Using a Silicone Band Retraction Method (With Video).Surgical laparoscopy, endoscopy & percutaneous techniques · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Åsmund Avdem Fretland
Airazat M Kazaryan
Bjørn Atle Bjørnbeth
Kjersti Flatmark
Marit Helen Andersen
Tor Inge Tønnessen
Gudrun Maria Waaler Bjørnelv
Morten Wang Fagerland
Ronny Kristiansen
Karl Øyri
Bjørn Edwin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLaparoscopic liver resection is used in specialized centers all over the world. However, laparoscopic liver resection has never been compared with open liver resection in a prospective, randomized trial. METHODS/

designThe Oslo-CoMet Study is a randomized trial into laparoscopic versus open liver resection for the surgical management of hepatic colorectal metastases. The primary outcome is 30-day perioperative morbidity. Secondary outcomes include 5-year survival (overall, disease-free and recurrence-free), resection margins, recurrence pattern, postoperative pain, health-related quality of life, and evaluation of the inflammatory response. A cost-utility analysis of replacing open surgery with laparoscopic surgery will also be performed. The study includes all resections for colorectal liver metastases, except formal hemihepatectomies, resections where reconstruction of vessels/bile ducts is necessary and resections that need to be combined with ablation. All patients will participate in an enhanced recovery after surgery program. A biobank of liver and tumor tissue will be established and molecular analysis will be performed. DISCUSSION: After 35 months of recruitment, 200 patients have been included in the trial. Molecular and immunology data are being analyzed. Results for primary and secondary outcome measures will be presented following the conclusion of the study (late 2015). The Oslo-CoMet Study will provide the first level 1 evidence on the benefits of laparoscopic liver resection for colorectal liver metastases.

trial registrationThe trial was registered in ClinicalTrals.gov (NCT01516710) on 19 January 2012.

Indexed as

Clinical ProtocolsColorectal NeoplasmsCost-Benefit AnalysisDisease-Free SurvivalHealth Care CostsHepatectomyHumansLaparoscopyLiver NeoplasmsMetastasectomyNeoplasm Recurrence, LocalNeoplasm, ResidualNorwayPain MeasurementPostoperative PainProspective Studies

Identifiers

PMID25872027
PMCPMC4358911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.